As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Rost-9D / Getty Images / iStock
Thematic Series Published in 2020: Non-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies
There is increasing evidence that non-coding RNAs play a major role in epigenetic regulation. This article collection focuses on understanding the mechanisms of non-coding RNA, describing insights into the biogenesis and activity of non-coding RNAs, their interaction with chromatin, and novel methods for analysis and manipulation of RNA-mediated regulation.
Editor-in-Chief
Christophe Nicot, Kansas University Medical Center, USA
Aims and scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Articles
-
-
Long noncoding RNAs: functions and mechanisms in colon cancer
-
circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway
-
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
-
The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation
-
Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
-
Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
-
The complexity of NF-κB signaling in inflammation and cancer
-
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
Call for Papers
Special Issue to be published in early 2021 on ‘mRNA-based therapies and vaccines for human cancers’
All papers selected by Editor in Chief, Professor Christophe Nicot
Submit your paper for consideration today - deadline for submission is November 30th, 2020
Featured Article: Role of the NLRP3 inflammasome in cancer
In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.
Thematic Series Published in 2019: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
This series of review articles aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.
Thematic Series Published in 2018
Series of Review Articles: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities
Follow
Annual Journal Metrics
-
Speed
53 days to first decision for reviewed manuscripts only
14 days to first decision for all manuscripts
109 days from submission to acceptance
22 days from acceptance to publication
Citation Impact
15.302 - 2-year Impact Factor
10.478 - 5-year Impact Factor
2.969 - Source Normalized Impact per Paper (SNIP)
4.581 - SCImago Journal Rank (SJR)Usage
1,270,828 Downloads
445 Altmetric mentions
